Do patients undergoing percutaneous coronary intervention benefit from clopidogrel pretreatment?

被引:2
|
作者
Weintraub, WS
机构
[1] Christiana Care Hlth Serv, Div Cardiol, Newark, DE 19718 USA
[2] Christiana Care Hlth Serv, Christiana Ctr Outcomes Res, Newark, DE 19718 USA
来源
关键词
clopidogrel; percutaneous coronary intervention; ST-segment elevation myocardial infarction;
D O I
10.1038/ncpcardio0398
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:12 / 13
页数:2
相关论文
共 50 条
  • [1] Do patients undergoing percutaneous coronary intervention benefit from clopidogrel pretreatment?
    William S Weintraub
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 12 - 13
  • [2] Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention
    Quinn, MJ
    Bhatt, DL
    Zidar, F
    Vivekananthan, D
    Chew, DP
    Ellis, SG
    Plow, E
    Topol, EJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (06): : 679 - 684
  • [3] Clopidogrel pretreatment reduces platelet inflammatory marker expression in patients undergoing percutaneous coronary intervention
    Zidar, FJ
    Quinn, MJ
    Bhatt, DL
    Vivekananthan, DP
    Aronow, HD
    Ellis, SG
    Plow, E
    Topol, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 45A - 45A
  • [4] Benefit of clopidogrel in patients undergoing percutaneous coronary intervention in the CURE trial receiving and not receiving an intracoronary Stent
    Mehta, SR
    Natarajan, MK
    Wittlinger, T
    Morais, J
    Keltai, M
    Rupprecht, HJ
    Bertrand, ME
    Fox, KA
    Yusuf, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 45A - 45A
  • [5] Correction to: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention
    Nejat Mahdieh
    Ahmad Rabbani
    Ata Firouzi
    Ali Zahedmehr
    Maryam Hoseinimoghaddam
    Sedigheh Saedi
    Hamidreza Sanati
    Hosseinali Basiri
    Feridoun Noohi
    Bahareh Rabbani
    Majid Maleki
    [J]. Cardiovascular Toxicology, 2018, 18 : 492 - 492
  • [6] Clopidogrel pretreatment effect according to the clinical presentation in patients undergoing percutaneous coronary intervention: a meta-analysis
    Bellemain-Appaix, A.
    O'Connor, S.
    Silvain, J.
    Cucherat, M.
    Beygui, F.
    Barthelemy, O.
    Collet, J-P.
    Jacq, L.
    Bernasconi, F.
    Montalescot, G.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 881 - 882
  • [7] The potential interaction of statins and clopidogrel in patients undergoing percutaneous coronary intervention
    Ibrahim, Tahani H.
    Alanazy, Hind S.
    Alharbi, Maram M.
    Ahmed, Safa M.
    [J]. INTERNATIONAL JOURNAL OF ADVANCED AND APPLIED SCIENCES, 2021, 8 (03): : 112 - 119
  • [8] Clopidogrel Pretreatment Effect according to the clinical presentation in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
    Bellemain-Appaix, Anne
    O'Connor, Stephen A.
    Silvain, Johanne
    Cucherat, Michel
    Collet, Jean-Philippe
    Bernasconi, Francois
    Montalescot, Gilles
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B250 - B250
  • [9] Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
    Yang, Bin
    Zheng, Chunyan
    Yu, Haichu
    Zhang, Rui
    Li, Shan
    Tan, Lijuan
    Leng, Min
    Cai, Shanglang
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2018, 47 (07) : 952 - 957
  • [10] CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
    Zeb, Shah
    Shah, Ibrahim
    Adil, Mohammad
    Ali, Jabar
    Jan, Hikmatullah
    Gul, Adnan Mahmood
    Hafizullah, Mohammad
    [J]. PAKISTAN HEART JOURNAL, 2016, 49 (03): : 107 - 112